The Ozempic Shortage Is Over
The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.
FDA gives compounders short reprieve as Novo Nordisk GLP-1 supply normalizes
Novo Nordisk's (NVO) weight loss therapy Wegovy/Ozempic come out of shortage, but the FDA won't crack down on compounders ...
STAT1d
Risky weight loss, grad school acceptance cuts, and more major biotech news of the day
Experts noted that rapid and extreme weight loss can introduce unique risks, such as a weakened immune system and malnourishment, as well as potentially too much muscle loss. They’re also concerned ...
infectiousdiseaseadvisor.com1d
Many With Overweight, Obesity Discontinue GLP-1 Receptor Agonists Within 1 Year
Many patients with overweight or obesity discontinue GLP-1 receptor agonist therapy within 1 year, with higher discontinuation rates seen for those without type 2 diabetes.
Hosted on MSN1d
Ascletis announces positive results in Phase Ib oral GLP-1RA trial
The Hong Kong company saw a reduction in body weight across both cohorts with no serious adverse events reported.
Hosted on MSN1d
GLP-1RAs and opioid use disorder: a new frontier in addiction treatment
Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...
KUOW16d
Understanding Ozempic — how GLP-1 has changed weight loss
After just a few years on the market, a new wave of GLP-1 drugs approved for weight loss have upended what we know about obesity. By now, these are household names: Mounjaro. Wegovy. Zepbound ...
Becker's Hospital Review16d
GLP-1 drug fails to slow Parkinson's: Study
A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. The 96-week trial, published in The ...
Medicine Buffalo16d
Ophthalmic complications in patients on antidiabetic GLP-1 medications are concerning neuro-ophthalmologists
BUFFALO, N.Y. — A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision ... they should call their internist about possibly adjusting the dosage or ...
Business Insider17d
Only 83 songs have debuted at No. 1 in the history of the Billboard Hot 100 — here they all are
Keep reading for a complete list of instant chart-toppers throughout history. 1. "You Are Not Alone" by Michael Jackson Michael Jackson was the first artist to achieve this feat with "You Are Not ...
The Lancet17d
First phase 3 trial of GLP-1 receptor agonist for neurodegeneration
Excluding people with type 2 diabetes from the trial might have resulted in a missed opportunity to establish whether people with both Parkinson's disease and type 2 diabetes could benefit from GLP-1 ...
Everyday Health20d
13 Celebrities Who Have Spoken Out About Taking GLP-1s
Adam Gilden, MD, MSCE, is an associate director of the Obesity Medicine Fellowship at University of Colorado School of Medicine and associate director of the Colorado University Medicine Weight ...